Binding sites for PNU-120596 are not in the agonist-binding sites and PNU-120596 enhances agonist-evoked gating of nicotinic receptors by eliciting conformational effects that are similar but nonidentical to the gating conformations promoted by Ach
2017024522
is a potent CXCR2 antagonist
2ClH/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23
also known as CA-4948 is a potent IRAK4/FLT3 inhibitor with anti-tumor activity
5'-Phosphoguanylyl-(3', 5')-guanosine Catalog No.:M17833-C Binding sites for PNU-120596 are5' Phosphoguanylyl (3',5') guanosine (pGpG) is an intermediate molecule produced by the pathway for enzymatic cyclic diguanylate (c di GMP) degradation. 5' Phosphoguanylyl (3',5') guanosine can be used to detect the metabolism of nucleic acids. Product information CAS Number: 33008 99 0 Molecular Weight: 708. 43 Formula: C20H26N10O15P2 Chemical Name: {[(2R, 3S, 4R, 5R) 5 (2 amino 6 oxo 6, 9 dihydro 3H purin 9 yl) 3 [({[(2R, 3S, 4R, 5R) 5 (2 amino 6